PTC
AVNS

Petrus Trust Company’s Avanos Medical AVNS Stock Holding History

Petrus Trust Company’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-10,900
Closed -$126K – 42
2025
Q3 		$126K Sell
10,900
-5,396
-33% -$63.2K 0.01% 147
2025
Q2 		$199K Hold
16,296
– – 0.02% 464
2025
Q1 		$234K Buy
+16,296
New +$254K 0.02% 487
2024
Q4 		– Sell
-16,368
Closed -$393K – 594
2024
Q3 		$393K Hold
16,368
– – 0.04% 318
2024
Q2 		$326K Hold
16,368
– – 0.03% 403
2024
Q1 		$326K Hold
16,368
– – 0.03% 399
2023
Q4 		$367K Buy
+16,368
New +$338K 0.03% 359

Other funds holding AVNS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Petrus Trust Company's AVNS Position: Q4 2025 in Review

Petrus Trust Company sold out of Avanos Medical (AVNS) in Q4 2025, closing a stake of 10,900 shares — an estimated $126K sold.

Petrus Trust Company first reported a position in AVNS in Q4 2023 and held it in 7 quarters. The position peaked at $393K in Q3 2024. 274 funds tracked by Wall St. Rank hold AVNS as of Q4 2025.

  • Petrus Trust Company reported no remaining Avanos Medical position as of Q4 2025 after selling out during the quarter.
  • Petrus Trust Company sold 10,900 Avanos Medical shares in Q4 2025, an estimated $126K.
  • Petrus Trust Company first reported a position in Avanos Medical in Q4 2023 and held it in 7 quarters.
  • Petrus Trust Company's Avanos Medical position peaked at $393K in Q3 2024.
  • 274 funds tracked by Wall St. Rank held Avanos Medical as of Q4 2025.

Based on Petrus Trust Company's 13F filing for Q4 2025, filed 17 Feb 2026.